Literature DB >> 19135196

Synergistic role of inflammation and insulin resistance as coronary artery disease risk factors in African Americans and Caucasians.

Erdembileg Anuurad1, Russell P Tracy, Thomas A Pearson, Kyoungmi Kim, Lars Berglund.   

Abstract

The separate roles of inflammation and insulin resistance (IR) in the pathogenesis of cardiovascular disease (CVD) are well recognized. We investigated whether presence of inflammation would modify coronary artery disease (CAD) risk prediction in subjects with or without IR. Insulin, glucose, CRP and fibrinogen levels were determined in 317 Caucasians and 222 African Americans undergoing diagnostic coronary angiography. Extent of CAD was defined by a composite score (0-75). The overall prevalence of IR (HOMA-IR>or=3.0) in Caucasians and African Americans was 32.5% and 22.9%, respectively (P<0.05). The degree of CAD (composite score) was higher in subjects with IR (20.7 vs. 14.5, P=0.014 and 20.1 vs. 13.1, P=0.031 for Caucasians and African Americans, respectively), and in a multiple regression model IR was an independent predictor for CAD in both groups. In both ethnic groups, subjects with a combination of IR and high CRP (>or=3mg/l) had significantly higher composite score compared to those with no IR and low CRP (<3mg/l) (21.2 vs. 13.9, P<0.05 and 20.9 vs. 10.2, P<0.05 for Caucasians and African Americans, respectively). Similarly, the composite score was significantly higher in subjects with IR and high fibrinogen (>or=340 mg/dl) compared to those with no IR and low fibrinogen. In conclusion, elevated levels of inflammatory markers were positively associated with IR. Further, a combination of IR and inflammation resulted in a higher degree of CAD in both Caucasians and African Americans. The results suggest that inflammation may potentiate the cardiovascular risk factor role of IR.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19135196      PMCID: PMC2700183          DOI: 10.1016/j.atherosclerosis.2008.11.028

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  34 in total

Review 1.  Atherosclerosis--an inflammatory disease.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1999-01-14       Impact factor: 91.245

2.  Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies.

Authors:  J Danesh; R Collins; P Appleby; R Peto
Journal:  JAMA       Date:  1998-05-13       Impact factor: 56.272

3.  Relationship between insulin resistance and partially oxidized LDL particles in healthy, nondiabetic volunteers.

Authors:  M Carantoni; F Abbasi; F Warmerdam; M Klebanov; P W Wang; Y D Chen; S Azhar; G M Reaven
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-05       Impact factor: 8.311

4.  Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications.

Authors:  E M Macy; T E Hayes; R P Tracy
Journal:  Clin Chem       Date:  1997-01       Impact factor: 8.327

5.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.

Authors:  P M Ridker; M Cushman; M J Stampfer; R P Tracy; C H Hennekens
Journal:  N Engl J Med       Date:  1997-04-03       Impact factor: 91.245

6.  Fibrinogen and risk of cardiovascular disease. The Framingham Study.

Authors:  W B Kannel; P A Wolf; W P Castelli; R B D'Agostino
Journal:  JAMA       Date:  1987-09-04       Impact factor: 56.272

7.  C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.

Authors:  John Danesh; Jeremy G Wheeler; Gideon M Hirschfield; Shinichi Eda; Gudny Eiriksdottir; Ann Rumley; Gordon D O Lowe; Mark B Pepys; Vilmundur Gudnason
Journal:  N Engl J Med       Date:  2004-04-01       Impact factor: 91.245

8.  Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study.

Authors:  B C Martin; J H Warram; A S Krolewski; R N Bergman; J S Soeldner; C R Kahn
Journal:  Lancet       Date:  1992-10-17       Impact factor: 79.321

9.  Dyslipidemias with desirable plasma total cholesterol levels and angiographically demonstrated coronary artery disease.

Authors:  M Miller; L A Mead; P O Kwiterovich; T A Pearson
Journal:  Am J Cardiol       Date:  1990-01-01       Impact factor: 2.778

10.  Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance.

Authors:  I Zavaroni; E Bonora; M Pagliara; E Dall'Aglio; L Luchetti; G Buonanno; P A Bonati; M Bergonzani; L Gnudi; M Passeri
Journal:  N Engl J Med       Date:  1989-03-16       Impact factor: 91.245

View more
  9 in total

1.  Age as a modulator of inflammatory cardiovascular risk factors.

Authors:  Erdembileg Anuurad; Byambaa Enkhmaa; Zeynep Gungor; Wei Zhang; Russell P Tracy; Thomas A Pearson; Kyoungmi Kim; Lars Berglund
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-06-23       Impact factor: 8.311

2.  Inflammatory Obesity Phenotypes, Gender Effects, and Subclinical Atherosclerosis in African Americans: The Jackson Heart Study.

Authors:  Albert Lin; Mary E Lacy; Charles Eaton; Adolfo Correa; Wen-Chih Wu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-12       Impact factor: 8.311

3.  The relationship of insulin resistance and extracoronary calcification in the multi-ethnic study of atherosclerosis.

Authors:  Geoffrey H Tison; Michael J Blaha; Matthew J Budoff; Ronit Katz; Juan J Rivera; Alain G Bertoni; Nathan D Wong; Roger S Blumenthal; Moyses Szklo; John Eng; Russell Tracy; Khurram Nasir
Journal:  Atherosclerosis       Date:  2011-07-06       Impact factor: 5.162

4.  Impact of vitamin D supplementation on inflammatory markers in African Americans: results of a four-arm, randomized, placebo-controlled trial.

Authors:  Paulette D Chandler; Jamil B Scott; Bettina F Drake; Kimmie Ng; Joann E Manson; Nader Rifai; Andrew T Chan; Gary G Bennett; Bruce W Hollis; Edward L Giovannucci; Karen M Emmons; Charles S Fuchs
Journal:  Cancer Prev Res (Phila)       Date:  2013-12-10

5.  Profiling the Oxylipin and Endocannabinoid Metabolome by UPLC-ESI-MS/MS in Human Plasma to Monitor Postprandial Inflammation.

Authors:  Sandra Gouveia-Figueira; Jana Späth; Angela M Zivkovic; Malin L Nording
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

6.  Relationship between neutrophil-lymphocyte ratio and insulin resistance in newly diagnosed type 2 diabetes mellitus patients.

Authors:  Meiqin Lou; Peng Luo; Ru Tang; Yixian Peng; Siyuan Yu; Wanjing Huang; Lei He
Journal:  BMC Endocr Disord       Date:  2015-03-02       Impact factor: 2.763

7.  Attenuated age-impact on systemic inflammatory markers in the presence of a metabolic burden.

Authors:  Anuurad Erdembileg; Annie Mirsoian; Byambaa Enkhmaa; Wei Zhang; Laurel A Beckett; William J Murphy; Lars F Berglund
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

8.  Differential associations of angiographic extent and severity of coronary artery disease with asymmetric dimethylarginine but not insulin resistance in non-diabetic men with stable angina: a cross-sectional study.

Authors:  Olga Kruszelnicka; Andrzej Surdacki; Alain Golay
Journal:  Cardiovasc Diabetol       Date:  2013-10-09       Impact factor: 9.951

Review 9.  Impact of Increased Oxidative Stress on Cardiovascular Diseases in Women With Polycystic Ovary Syndrome.

Authors:  Florentina Duică; Cezara Alina Dănilă; Andreea Elena Boboc; Panagiotis Antoniadis; Carmen Elena Condrat; Sebastian Onciul; Nicolae Suciu; Sanda Maria Creţoiu; Valentin Nicolae Varlas; Dragoş Creţoiu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-18       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.